|

Diabetes Clinical Trials in Alabama

51 recruiting studies across 14 cities

All Trials in Alabama

Phase
Trial Phase Location
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesPhase 3Anniston
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityPhase 3Anniston
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 3Anniston
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric PatientsN/ABirmingham
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMPhase 3Birmingham
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusPhase 3Birmingham
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesPhase 2Birmingham
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightPhase 3Birmingham
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Phase 3Birmingham
A Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusPhase 2Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPhase 3Birmingham
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinPhase 3Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesPhase 3Birmingham
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesPhase 2Birmingham
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusPhase 3Birmingham
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarPhase 3Birmingham
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightPhase 3Birmingham
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsPhase 3Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)N/ABirmingham
CARBON: UAB Cardiovascular Research Biobank—Birmingham
CGM for Management of Type 2 Diabetes in PregnancyN/ABirmingham
CGM for the Early Detection and Management of Hyperglycemia in PregnancyN/ABirmingham
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth—Birmingham
Denosumab for Type 1 DiabetesPhase 1/2Birmingham
Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes?N/ABirmingham
FELLAShip to Better HealthN/ABirmingham
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy—Birmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)N/ABirmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)N/ABirmingham
Implementing AI-based Glaucoma Screening Within Federally Qualified Health CentersN/ABirmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities—Birmingham
Inspire HER: Inspiring the Heart and Emotions for Radical HealthN/ABirmingham
Intensive Glycemic Targets in Overweight and Obese Women With Gestational DiabetesN/ABirmingham
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)—Birmingham
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black IndividualsPhase 2Birmingham
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes MellitusPhase 2Birmingham
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based TherapyPhase 2Birmingham
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)—Birmingham
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Decatur
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusPhase 3Dothan
Maturation of Arteriovenous Fistula With Automated Sonography Assessments TrialN/ADothan
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightPhase 3Fairhope
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesPhase 3Guntersville
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusPhase 3Huntsville
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventPhase 2Huntsville
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesPhase 4Huntsville
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney DiseasePhase 2Huntsville
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2Mobile
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without DiabetesPhase 2Mobile
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesPhase 3Tuscaloosa
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesPhase 4Tuscaloosa

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.